In the past, the work of the Food and Drug Administration was often bogged down by bureaucratic processes and the red tape of a regulatory environment. The drug approval department could be inefficient, and it didn’t always put patients at the center of the process.

In a new era for the FDA, the focus is on patients. Patients and patient advocacy groups are getting more involved, and KidneyCAN is leading the way.

Today, on February 5th, Bryan Lewis, president of KidneyCAN, visited the FDA for a stakeholders’ meeting called “Envisioning Oncology Product Development for 2025” at the Oncology Center of Excellence (OCE). The mission of the Oncology Center of Excellence is to “achieve patient-centered regulatory decision-making through innovation and collaboration.” The purpose of this meeting was to update the stakeholders on new happenings at the OCE.

Food and Drug Administration

We learned about a number of remarkable initiatives at the OCE, including the following projects:

  • Project Socrates aims to provide insight into the FDA’s role in oncology drug development and the multidisciplinary and team-based approach the FDA takes in this process.
  • Project Facilitate is a single point of contact where FDA oncology staff will help physicians and their healthcare team through the process to submit an Expanded Access request for an individual patient with cancer.
  • Project Renewal is a public health initiative that aims to update the labeling information for oncology products by evaluating relevant scientific evidence from published literature.
  • Project Orbis provides a framework for concurrent submission and review of oncology products among international partners.

Project Orbis supports the global collaboration of cancer research endeavors.

One initiative that really caught our attention is called Project Patient Voice.

OCE Project Patient Voice: Project Patient Voice is an initiative by the OCE that records patient reports of adverse effects during clinical trials for cancer.

This is a pilot website describing patient-reported adverse event data from trials.

We’re so grateful to see patient input included in the process of oncology research. KidneyCAN will continue advocating for the kidney cancer community at events such as these.

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Deb Beyhan is the Patient Legislative Advocate for KidneyCAN. She was diagnosed with stage IV kidney cancer in 2016 at the age of 53. Deb lives outside of Atlanta, GA, with her husband.    For this month's Community Spotlight, we want to tell you about a member of our volunteer team, Deb Beyhan....

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

District Days: Asking Congress to Fund Kidney Cancer Research

District Days: Asking Congress to Fund Kidney Cancer Research

On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

The 2022 Kidney Cancer Research Summit

The 2022 Kidney Cancer Research Summit

Dr. Laurence Albiges (Institut Gustave Roussy) presents on the microbiome at KCRS22. The microbiome has now been recognized as one of the emerging hallmarks and enabling characteristics of cancer. KidneyCAN hosted the 4th Annual Kidney Cancer Research Summit on October 6-7, 2022  live in...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Rock the Run for Kidney Cancer Research Funding

Rock the Run for Kidney Cancer Research Funding

KidneyCAN had the first ever Rock the Run 5k fundraiser in October 2022. This is part of the group of KCRS22 attendees who walked and ran with us at dawn before the second conference day began. KidneyCAN is proud to share the results of the first annual Rock the Run 5K fundraiser. Our Purpose...